Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
– Sell
-21,800
Closed -$376K – 4209
2024
Q4
$376K Buy
21,800
+1,900
+10% +$38K ﹤0.01% 3781
2024
Q3
$449K Buy
+19,900
New +$455K ﹤0.01% 3764
2021
Q1
– Sell
-40,000
Closed -$1.39M – 3996
2020
Q4
$1.39M Sell
40,000
-10,000
-20% -$282K ﹤0.01% 2803
2020
Q3
$866K Hold
50,000
– – ﹤0.01% 2943
2020
Q2
$821K Buy
+50,000
New +$760K ﹤0.01% 3058
2019
Q4
– Sell
-90,100
Closed -$2.07M – 3931
2019
Q3
$2.07M Sell
90,100
-95,300
-51% -$2.17M ﹤0.01% 2321
2019
Q2
$4.5M Buy
185,400
+91,700
+98% +$1.89M 0.01% 1662
2019
Q1
$1.21M Buy
93,700
+67,300
+255% +$1.18M ﹤0.01% 2490
2018
Q4
$398K Sell
26,400
-92,600
-78% -$2.4M ﹤0.01% 3216
2018
Q3
$4.68M Buy
119,000
+113,100
+1,917% +$5.1M 0.01% 1618
2018
Q2
$290K Sell
5,900
-37,200
-86% -$2.11M ﹤0.01% 3391
2018
Q1
$2.58M Buy
43,100
+20,000
+87% +$1.33M ﹤0.01% 1875
2017
Q4
$1.82M Buy
23,100
+3,100
+16% +$250K ﹤0.01% 2203
2017
Q3
$1.68M Hold
20,000
– – ﹤0.01% 2156
2017
Q2
$1.31M Hold
20,000
– – ﹤0.01% 2247
2017
Q1
$1.45M Buy
+20,000
New +$1.31M ﹤0.01% 2053

Other funds holding ADNT

David Shaw's ADNT Position: Q3 2026 in Review

David Shaw reduced its Adient (ADNT) stake by 3.7% in Q3 2026, selling an estimated $2.21M and leaving 2,984,119 shares worth $50.3M. The position accounts for 0.02% of the portfolio, ranked #754.

David Shaw first reported a position in ADNT in Q4 2016 and has held it in 33 quarters since. The position peaked at $74.9M in Q3 2025. 302 funds tracked by Wall St. Rank hold ADNT as of Q3 2026.

  • David Shaw held 2,984,119 shares of Adient worth $50.3M as of Q3 2026.
  • David Shaw sold 114,589 Adient shares in Q3 2026, an estimated $2.21M.
  • Adient made up 0.02% of David Shaw's portfolio in Q3 2026, its #754 holding.
  • David Shaw first reported a position in Adient in Q4 2016 and has held it in 33 quarters since.
  • David Shaw's Adient position peaked at $74.9M in Q3 2025.
  • 302 funds tracked by Wall St. Rank held Adient as of Q3 2026.

Based on D.E. Shaw & Co's 13F filing for Q3 2026, filed 16 Nov 2026.